In recent years, some studies have demonstrated that CCL2 can be considered as an independent prognostic factor for bladder cancer [23], clear-cell renal cell carcinoma [24], and gastric cancer [9], together with our findings, further highlighting a significant value of CCL2 in human cancer prognosis. This evidence concerns the gene CCL2 and urinary bladder carcinoma.